In conditions like obesity and T2D, persistent low-grade inflammation disrupts the hepcidin–ferroportin cycle, contributing to iron misdistribution, functional iron deficiency, and anemia of chronic disease (ACD)/anemia of inflammation (AI) [205]. The gene discussed is HAMP; the disease is type 2 diabetes mellitus.